PCN95 Effect of Earlier Use of Ibrutinib on Healthcare Resource Utilization (HRU) and Costs Among Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) in the United States
Abstract
Authors
S. Challagulla P. Lee N. Giafis A.M. Manceur I. Fakih B. Emond R. Iyengar